Trials / Conditions / Acute Respiratory Infection

Acute Respiratory Infection

71 registered clinical trials studyying Acute Respiratory Infection — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	ORCHARDS-AIR Study NCT07298967	University of Wisconsin, Madison	N/A
Recruiting	Effectiveness and Implementation of a National Guideline for Acute Respiratory Tract Infections to Reduce Anti NCT07396428	Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland	N/A
Withdrawn	Reusable Face Masks to Reduce Risk of Viral Respiratory Infections and Asthma Exacerbations NCT06885229	Queen Mary University of London	Phase 2
Active Not Recruiting	Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Eme NCT06271655	Christopher Payette	N/A
Unknown	Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Vir NCT06315400	Valenta Pharm JSC	Phase 4
Recruiting	Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections NCT06379542	Valenta Pharm JSC	Phase 3
Completed	Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza NCT06183229	POLYSAN Scientific & Technological Pharmaceutical Company	Phase 3
Not Yet Recruiting	Isotonic Saline for Children With Bronchiolitis NCT05902702	Slagelse Hospital	N/A
Recruiting	POS-ARI-ER Observational Study of Acute Respiratory Infections NCT05814237	European Clinical Research Alliance for Infectious Diseases (ECRAID)	—
Completed	ASPIRE II. Supporting Antibiotic Stewardship in Primary Care Via POCT NCT06981130	University of South Wales	N/A
Unknown	Clinical Trial of Natural Therapeutics for COVID-19 and Other Acute Respiratory Viral Infections NCT05897203	Makerere University	Phase 2
Completed	A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus NCT06385821	NPO Petrovax	Phase 3
Completed	ASPIRE I: Supporting Antibiotic Stewardship in Primary Care Via POCT NCT06912022	University of South Wales	—
Completed	Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute NCT05273619	Valenta Pharm JSC	Phase 3
Withdrawn	Prevention of Acute Respiratory Infection in Taiwanese Institutionalized Elderly NCT04938323	Harvard Medical School (HMS and HSDM)	Phase 2 / Phase 3
Completed	Urgent Care Management of Respiratory Illness Enabled With Novel Testing Pathway NCT05467007	Andrew Meltzer	N/A
Completed	Improving Safe Antibiotic Prescribing in Telehealth NCT05138874	University of Southern California	N/A
Completed	Decreasing Antibiotic Prescribing in Acute Respiratory Infections Through Nurse Driven Clinical Decision Suppo NCT04255303	NYU Langone Health	N/A
Completed	Clinical Decision Rules in the Emergency Department to Improve the Management of Acute Respiratory Infection a NCT05322694	Simon Berthelot	—
Completed	A Study of Acute Respiratory Infections in Global Outpatient Setting NCT05148780	Janssen Research & Development, LLC	EARLY_Phase 1
Completed	Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory V NCT05269290	Valenta Pharm JSC	Phase 3
Completed	Prophylaxis and Treatment of COVID-19 NCT04844541	Henry M. Jackson Foundation for the Advancement of Military Medicine	—
Completed	Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute NCT05269329	Valenta Pharm JSC	Phase 2
Terminated	Apple Respiratory Study NCT04912180	Apple Inc.	—
Unknown	Early Identification and Severity Prediction of Acute Respiratory Infectious Disease NCT04955756	Huashan Hospital	N/A
Recruiting	Signature of the Host Response to a Respiratory Viral Infection, in the Prediction of Bronchiolitis Obliterans NCT04099082	Assistance Publique - Hôpitaux de Paris	—
Unknown	Capnodynamic Monitoring of Cardiorespiratory Function in Critically Ill Patients NCT05082168	South West Sydney Local Health District	—
Unknown	Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition NCT04403100	Cardresearch	Phase 3
Completed	Implementation of CRP Point of Care Testing in Primary Care to Improve Antibiotic Targeting in Respiratory Ill NCT03855215	Oxford University Clinical Research Unit, Vietnam	N/A
Unknown	Energy Supply in Athletes and Untrained Persons With Bronchopulmonary Diseases NCT04415827	I.M. Sechenov First Moscow State Medical University	N/A
Completed	Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease NCT04332991	Massachusetts General Hospital	Phase 3
Completed	Improving Nighttime Access to Care and Treatment (Part 2) NCT03943654	University of Florida	—
Completed	Online Learning Portal on Under Five Pneumonia NCT04495361	University of Edinburgh	N/A
Completed	The RAPID Trial: Assessing Point-of-care Influenza and Other Respiratory Virus Diagnostics NCT03756753	University of Colorado, Denver	N/A
Completed	Efficacy and Safety of Polyoxidonium, Nasal and Sublingual Spray, 6 mg/ml in Children Aged 1-12 Years With ARI NCT03840135	NPO Petrovax	Phase 3
Completed	Molecular Diagnosis of Respiratory Viral Infections on Sputum From Cystic Fibrosis Patients NCT03736096	University Hospital, Brest	—
Unknown	Impact of Improved "Injera" Baking Stove Use on Childhood Acute Respiratory Infection Prevention in Northwest NCT03612362	Bahir Dar University	N/A
Unknown	Liberia National Community Health Assistant (NCHA) Program and Under-five Mortality NCT05123378	Last Mile Health	N/A
Completed	Pneumonia Case Management Practices in Pakistan NCT03869099	University of Edinburgh	—
Completed	Collection of Clinical Specimens From Volunteers for Assay Development NCT03606382	Inflammatix	—
Completed	mHealth for Pneumonia Prevention NCT04493047	University of Edinburgh	N/A
Completed	Children's Automated Respiration Monitor (ChARM) for Child Pneumonia Diagnosis by Community Health Workers in NCT03457519	Diego Bassani	N/A
Completed	Kent State University / Price Chopper Employee Wellness Study NCT03454009	Kent State University	N/A
Completed	FluSAFE: Flu SMS Alerts to Freeze Exposure NCT03274310	Columbia University	N/A
Completed	Pediatric Pneumonia Lung Ultrasound NCT03187067	Save the Children	—
Withdrawn	Airway Inflammatory Response During Illness in Children With Respiratory Failure NCT02047877	University of North Carolina, Chapel Hill	—
Completed	Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers NCT03459391	PHARMENTERPRISES LLC	Phase 1
Completed	Assessment of Pharyngeal Carriage of Microorganisms Responsible for Transmissible Acute Respiratory Infections NCT02868541	Assistance Publique Hopitaux De Marseille	—
Unknown	Dialogue Around Respiratory Illness Treatment NCT02943551	Seattle Children's Hospital	N/A
Completed	Clinical Evaluation of the Use of an mHealth Intervention on Quality of Care NCT03874143	World Vision Canada	N/A
Completed	XC8 in the Treatment of Patients With Acute Respiratory Viral Infection NCT03441373	PHARMENTERPRISES LLC	Phase 2 / Phase 3
Completed	Effects of GS-3K8 and GINst15 on Acute Respiratory Illness NCT03028077	Chonbuk National University Hospital	N/A
Completed	Maltese Antibiotic Stewardship Programme in the Community (MASPIC): Antibiotic Prescribing for Acute Respirato NCT03218930	Karolinska Institutet	N/A
Completed	Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children NCT03191097	Valenta Pharm JSC	Phase 3
Completed	CPAP Survival Study in Ghana NCT01839474	Columbia University	N/A
Completed	University of Wisconsin Meditation & Exercise Cold Study NCT01654289	University of Wisconsin, Madison	Phase 2
Completed	Zinc Sulphate vs. Zinc Amino Acid Chelate NCT01791608	CES University	Phase 4
Completed	Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients NCT03206346	Valenta Pharm JSC	Phase 3
Completed	Efficacy and Tolerance of a Follow-On Formula Fed to Children From 36-48 Months of Age NCT01488435	Mead Johnson Nutrition	N/A
Completed	Efficacy and Tolerance of a Follow-On Formula Fed to Children From 12-48 Months of Age in Salvador, Bahia, Bra NCT01431469	Mead Johnson Nutrition	N/A
Completed	Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections NCT03189537	Valenta Pharm JSC	Phase 3
Unknown	Surveillance of Influenza in Paediatric Intensive Care Units in Bavaria NCT01286285	University Children's Hospital, Wuerzburg	—
Completed	Evaluating the Effect of Mucinex 1200mg on Mucociliary and Cough Clearance During an Acute Respiratory Infecti NCT01114581	Reckitt Benckiser LLC	Phase 2
Completed	Oral Supplement for Pregnant and Lactating Mothers NCT01073033	Société des Produits Nestlé (SPN)	N/A
Completed	Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections i NCT03154515	Valenta Pharm JSC	Phase 4
Completed	Direct and Indirect Benefits of Influenza Vaccination in Schools and Households NCT00981513	The University of Hong Kong	Phase 4
Completed	Meditation and Exercise for Prevention of Acute Respiratory Infection NCT01057771	University of Wisconsin, Madison	Phase 2 / Phase 3
Completed	Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza NCT01693380	Butantan Institute	Phase 4
Completed	"Alcohol Based Hand Sanitizers for the Prevention of Acute Diarrheal Disease and Acute Respiratory Infection i NCT00963391	Fundación Santa Fe de Bogota	N/A
Unknown	Middle Meatal Bacteriology During Acute Respiratory Infection in Children NCT00545961	Oulu University Hospital	Phase 4
Completed	Phase 4 Study - Mucinex D as Adjunct Therapy NCT00441246	Adams Respiratory Therapeutics	Phase 4